Fight Aging! Newsletter Explores Epigenetic Clocks and Genetic Secrets of Longevity
November 3, 2024Bats are examined for their remarkable lifespans and resistance to cancer, providing valuable insights into the genetic factors that may contribute to longevity and cancer suppression.
A significant theme in the newsletter is the concept of epigenetic clocks, which suggest that aging may be a programmed process rather than just a byproduct of evolution, opening avenues for potential therapies.
The discussion includes findings that centenarians typically possess fewer harmful genetic mutations, hinting at a heritable component to longevity that could be transmitted across generations.
Overall, the newsletter covers a range of topics including extracellular vesicle therapy, DNA methylation, epigenetic clocks, and the genetic determinants of longevity, reflecting the ongoing research in the field.
Fight Aging! is a widely-read newsletter that provides news and commentary on combating age-related diseases through modern medicine, attracting thousands of subscribers each week.
Research highlighted in the newsletter indicates that changes in DNA methylation are linked to species longevity, revealing a complex relationship between individual aging and maximum lifespan.
The newsletter also explores the potential role of weakened intestinal barriers, which may lead to the leakage of digestive enzymes into the body, as a contributing factor to degenerative aging, though further research is necessary.
Extracellular vesicle therapy is presented as a promising treatment for neurological disorders, yet it faces challenges related to standardization and the understanding of different vesicle subtypes.
The newsletter features insights from Reason, the founder of Fight Aging! and Repair Biotechnologies, who offers consulting services for the longevity industry to investors and entrepreneurs.
Summary based on 1 source
Get a daily email with more Science stories
Source
Fight Aging! • Nov 2, 2024
Fight Aging! Newsletter, November 4th 2024